Mydriasis: a dilation of the pupil.
This is a real world study of Mydriasis among people who take Oxymetazoline Hydrochloride 0.05% 388. The study is created by eHealthMe based on 28 reports from FDA and social media.
What is the drug
Oxymetazoline hydrochloride 0.05% 388 (latest outcomes) has active ingredients of oxymetazoline hydrochloride. It is often used in nasopharyngitis.
On Jan, 31, 2015: 28 people reported to have Mydriasis when taking Oxymetazoline Hydrochloride 0.05% 388 are studied.
Gender of people who have Mydriasis when taking the drug * :
Age of people who have Mydriasis when taking the drug * :
Severity of Mydriasis when taking the drug ** :
How people recovered from Mydriasis ** :
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
More about the drug combination: Oxymetazoline Hydrochloride 0.05% 388 drug interactions
You can also:
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.